Mueller D

Title : Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using (177)Lu-FAP-2286: First-in-Humans Results - Baum_2022_J.Nucl.Med_63_415

Author(s) : Baum RP , Schuchardt C , Singh A , Chantadisai M , Robiller FC , Zhang J , Mueller D , Eismant A , Almaguel F , Zboralski D , Osterkamp F , Hoehne A , Reineke U , Smerling C , Kulkarni HR

Ref : J Nucl Med , 63 :415 , 2022

Abstract :

PubMedSearch : Baum_2022_J.Nucl.Med_63_415

PubMedID: 34168013

Title : Novel Genetic Variants in Carboxylesterase 1 Predict Severe Early-Onset Capecitabine-Related Toxicity - Hamzic_2017_Clin.Pharmacol.Ther_102_796

Author(s) : Hamzic S , Kummer D , Milesi S , Mueller D , Joerger M , Aebi S , Amstutz U , Largiader CR

Ref : Clinical Pharmacology & Therapeutics , 102 :796 , 2017

Abstract :

PubMedSearch : Hamzic_2017_Clin.Pharmacol.Ther_102_796

PubMedID: 28139840

Gene_locus related to this paper: human-CES1

Mueller D

References (2)

1. Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using (177)Lu-FAP-2286: First-in-Humans Results - Baum_2022_J.Nucl.Med_63_415

2. Novel Genetic Variants in Carboxylesterase 1 Predict Severe Early-Onset Capecitabine-Related Toxicity - Hamzic_2017_Clin.Pharmacol.Ther_102_796